Search results
AstraZeneca Singapore is one of Singapore’s leading biopharmaceutical companies that aim to make a difference in the healthcare industry by touching and saving as many lives as we can through our innovation in the scientific medical field.
May 20, 2024 · AstraZeneca plans to build a US$1.5 billion manufacturing facility in Singapore to produce antibody-drug conjugates (ADCs) and targeted cancer therapies, the British company said on Monday (May...
May 20, 2024 · AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio. ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody.
May 21, 2024 · SINGAPORE – Global biopharmaceutical company AstraZeneca intends to build a US$1.5 billion (S$2 billion) manufacturing facility in Singapore, the company said on May 20.
May 20, 2024 · AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish...
Aug 1, 2022 · SINGAPORE: The Health Sciences Authority (HSA) on Monday (Aug 1) granted interim authorisation for AstraZeneca's COVID-19 antibody drug for adults who are medically unsuitable for vaccination...
Dec 3, 2021 · On 25 November 2021, AstraZeneca Singapore signed Memorandums of Understanding (MOUs) with five technology partners, in the presence of the Singapore Ministry of Health and the Swedish Ministry of Health at the Singapore-Sweden Digital Healthcare RESET Dialogue.
May 20, 2024 · Pharmaceutical giant AstraZeneca is to open a $1.5 billion (€1.38 billion) cancer manufacturing plant in Singapore, as part of a plan to develop and strengthen its presence around the world.
Dec 11, 2021 · SINGAPORE: Biopharmaceutical company, AstraZeneca, will deliver its antibody drug for COVID-19 treatment to Singapore by end of this year. The company has signed a new purchase agreement with...
May 20, 2024 · AstraZeneca is investing $1.5bn in a manufacturing site in Singapore dedicated to the production of antibody drug conjugates, an advanced form of chemotherapy that the drugmaker believes could...
